Table 2 Effect of lipid-lowering medications on outcomes
Outcome | Non-LLT Group | LLT Group | P value | PS adjusted Non-LLT | PS adjusted LLT | P value |
|---|---|---|---|---|---|---|
In-hospital complications, N (%) | 300(39.3) | 1086(33.7) | 0.004 | 1508.9(37.2) | 1339.8(33.6) | 0.109 |
Infection, N (%) | 8(0.9) | 40(1.2) | 0.493 | 38.3(0.9) | 45.9(1.2) | 0.639 |
Stroke, N (%) | 21(2.7) | 48(1.5) | 0.025 | 123.9(3.1) | 59.4(1.5) | 0.016 |
Other neurologic complications, N (%) | 29(3.8) | 76(2.4) | 0.035 | 163.1(4.0) | 93.3(2.3) | 0.033 |
Ventilation prolong, N (%) | 129(16.9) | 453(14.1) | 0.053 | 623.7(15.4) | 567.5(14.3) | 0.495 |
Renal failure, N (%) | 29(3.8) | 133(4.1) | 0.754 | 169.9(4.2) | 165.1(4.1) | 0.964 |
Renal dialysis, N (%) | 11(1.4) | 64(2.0) | 0.396 | 65.5(1.6) | 79.8(2.0) | 0.563 |
New onset AF, N (%) | 192(25.1) | 797(24.7) | 0.850 | 979.9(24.2) | 979.4(24.6) | 0.824 |
Total ICU hours, Mean [17] | 121.9(343.1) | 102.6(156.2) | 0.020 | 116.7(305.3) | 103.7(158.2) | 0.685 |
Length of hospital stay, Mean [17] | 9.30(8.49) | 9.39(35.73) | 0.947 | 8.87(7.66) | 9.36(33.24) | 0.430 |
In-hospital Mortality, N (%) | 13(1.7) | 39(1.2) | 0.368 | 84.5(2.1) | 51.1(1.3) | 0.213 |
30d Mortality, N (%) | 15(2.0) | 49(1.5) | 0.473 | 79.8(2.0) | 62.1(1.6) | 0.539 |
Overall Mortality, N (%) | 111(14.5) | 361(11.2) | 0.012 | 606.2(14.9) | 448.9(11.3) | 0.017 |